BTL, Inc. AI Stock Analysis
BTL, Inc. (6840) AI Stock Analysis
BTL, Inc.
(TPEx:6840)
The overall score is constrained by extremely weak technicals, which signal strong bearish momentum and a stock in freefall. While the company's financial recovery is a positive, it is overshadowed by the market's current negative sentiment. The persistent inability to generate positive free cash flow is a key fundamental risk that aligns with the poor technical picture. The valuation is neutral, offering little support.
BTL, Inc. (6840) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 2.04B
- Dividend Yield
- 1.47%
- Average Volume (3M)
- 433.25K
- Price to Earnings (P/E)
- 40.5
- Beta (1Y)
- 1.25
- Revenue Growth
- 13.53%
- EPS Growth
- 65.33%
- Country
- TW
- Employees
- 122
- Sector
- General
- Sector Strength
- 55
- Industry
- Specialty Business Services
BTL, Inc. Business Overview & Revenue Model
Company Description
BTL, Inc. provides testing and certification services for electronic products. Its products include mobile communications, BQB, Sar/Ota, IoT, EMC, RF, telecom, safety and new energy. It offers certifications for electromagnetic compatibility (EMC), r...
BTL, Inc. Financial Statement Overview
Summary
The company is in a clear recovery phase with revenue growth and expanding margins, but profitability remains well below historical peaks. The balance sheet is stable with low leverage, yet returns on equity are modest. Persistent negative free cash flow is a significant concern, indicating heavy capital spending that is not yet generating shareholder returns.
Income Statement
72PositiveBalance Sheet
65PositiveCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 961.85M | 909.14M | 838.24M | 702.81M | 888.20M | 825.06M |
| Gross Profit | 383.43M | 374.46M | 315.50M | 230.01M | 438.97M | 437.85M |
| EBITDA | 233.23M | 204.16M | 165.76M | 66.87M | 272.72M | 246.07M |
| Net Income | 66.05M | 47.96M | 15.50M | -53.45M | 134.92M | 129.16M |
Balance Sheet | ||||||
| Total Assets | 1.84B | 1.76B | 1.68B | 1.51B | 1.38B | 1.28B |
| Cash, Cash Equivalents and Short-Term Investments | 207.04M | 260.02M | 371.80M | 234.01M | 241.26M | 357.94M |
| Total Debt | 587.82M | 571.20M | 543.34M | 553.62M | 463.45M | 434.07M |
| Total Liabilities | 764.41M | 710.67M | 669.99M | 704.59M | 627.26M | 603.67M |
| Stockholders Equity | 1.08B | 1.05B | 1.01B | 808.61M | 753.41M | 673.23M |
Cash Flow | ||||||
| Free Cash Flow | -10.89M | -26.23M | 13.12M | -127.83M | -74.47M | 157.15M |
| Operating Cash Flow | 179.04M | 170.53M | 94.49M | 33.19M | 170.44M | 224.79M |
| Investing Cash Flow | -147.75M | -114.25M | -118.19M | -135.04M | -150.85M | -128.36M |
| Financing Cash Flow | -35.95M | -86.04M | 138.05M | 127.91M | -59.67M | -35.37M |
BTL, Inc. Peers Comparison
Overall Rating
TW:652773Outperform
TW:411662Neutral- TW:684054Neutral
TW:655847Neutral
TW:679640Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TW:6527 | 73Outperform | TWD 1.86B | 12.15 | ― | 3.98% | -1.23% | 10.20% |
| TW:4116 | 62Neutral | TWD 1.82B | 2.38 | ― | 4.91% | 3.85% | 786.65% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| TW:6840 | 54Neutral | TWD 2.09B | 40.48 | ― | 1.47% | 13.53% | 65.33% |
| TW:6558 | 47Neutral | TWD 1.81B | -10.57 | ― | 1.55% | -10.07% | -349.71% |
| TW:6796 | 40Underperform | TWD 2.04B | 123.00 | ― | 0.51% | 12.26% | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:6840 | BTL, Inc. | 65.10 | 7.99 | 13.99% | |
| TW:4116 | BenQ Medical Technology Corp. | 40.80 | -2.53 | -5.83% | |
| TW:6527 | Crystalvue Medical Co Ltd | 72.80 | -5.63 | -7.18% | |
| TW:6558 | SYNergy ScienTech Corp. | 19.30 | -18.20 | -48.53% | |
| TW:6796 | Medimaging Integrated Solution Inc. | 48.40 | -39.94 | -45.21% | |
| TW:7881 | Eyecare Tech, Inc. | 72.00 | -37.09 | -34.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026